Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis

被引：0
|
作者：
Xiao Zhang
Zhengyang Yang
Yongbo An
Yishan Liu
Qi Wei
Fengming Xu
Hongwei Yao
Zhongtao Zhang
机构：
[1] Capital Medical University,Department of General Surgery, Beijing Friendship Hospital
来源：
World Journal of Surgical Oncology | / 20卷
关键词：
Immune checkpoint inhibitors; Colorectal neoplasms; Meta-analysis; Clinical efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Zhang, Xiao
    Yang, Zhengyang
    An, Yongbo
    Liu, Yishan
    Wei, Qi
    Xu, Fengming
    Yao, Hongwei
    Zhang, Zhongtao
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [2] Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Quan Rao
    Min Li
    Wei Xu
    Kai Pang
    XiaoBo Guo
    Dong Wang
    Jun Liu
    Wei Guo
    ZhongTao Zhang
    [J]. Hepatology International, 2020, 14 : 765 - 775
  • [3] Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Rao, Quan
    Li, Min
    Xu, Wei
    Pang, Kai
    Guo, XiaoBo
    Wang, Dong
    Liu, Jun
    Guo, Wei
    Zhang, ZhongTao
    [J]. HEPATOLOGY INTERNATIONAL, 2020, 14 (05) : 765 - 775
  • [4] Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
    Liu, Surui
    Gao, Wei
    Ning, Yan
    Zou, Xiaomeng
    Zhang, Weike
    Zeng, Liangjie
    Liu, Jie
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Comparative Safety of PD-1/PD-L1 Inhibitors for Cancer Patients: Systematic Review and Network Meta-Analysis
    Huang, Ya-Fang
    Xie, Wen-Jie
    Fan, Hai-Yu
    Du, Juan
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
    Chen, Shixue
    Zhang, Zhibo
    Zheng, Xuan
    Tao, Haitao
    Zhang, Sujie
    Ma, Junxun
    Liu, Zhefeng
    Wang, Jinliang
    Qian, Yuanyu
    Cui, Pengfei
    Huang, Di
    Huang, Ziwei
    Wu, Zhaozhen
    Hu, Yi
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis
    Xiao, Bo-Ya
    Lin, Guo-He
    Zhao, Yan-Xia
    Wang, Bi-Cheng
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (06) : 3804 - 3818
  • [8] PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review
    Dai, Yun
    Muaibati, Munawaer
    Xie, Weiming
    Abasi, Abuduyilimu
    Li, Kexin
    Tong, Qing
    Zhang, Tao
    Meng, Yifan
    Zhuang, Liang
    Huang, Xiaoyuan
    [J]. CANCER INVESTIGATION, 2022, 40 (03) : 293 - 309
  • [9] Benefits and risks of PD-1/PD-L1 inhibitors for recurrent small cell lung cancer: A systematic review and meta-analysis
    Zhou, Juyue
    Du, Zhonghai
    Liang, Yan
    Zhang, Sensen
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 193
  • [10] Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Wen, Wen
    Zhang, Yong
    Zhang, Hua
    Chen, Yingshuang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 969 - 978
12345